# US FDA flags 3 issues at Dr Reddy’s Srikakulam plant 2026-08-08T05:53:59+00:00 | Governance | Indian Opinion Desk Corroboration: 1 independent outlet Dr Reddy’s Laboratories has received three observations from the US Food and Drug Administration after an inspection at its Srikakulam facility in Andhra Pradesh. The Pre-Approval Inspection and Good Manufacturing Practices check were carried out from July 20 to July 29, the company said in a filing on July 29. The regulator issued a Form 483 with three observations, which the drugmaker said it would address within the stipulated timeline. Shares of Dr Reddy's closed flat at Rs 1,144.35 on the BSE on Thursday. The facility is the FTO-SEZ Process Unit-02. ## Coverage - thehindu.com Tags: Dr Reddy's, Form 483, GMP inspection, pharma regulation, Srikakulam, US FDA Canonical: https://indianopinion.org/us-fda-flags-3-issues-at-dr-reddys-srikakulam-plant/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/us-fda-flags-3-issues-at-dr-reddys-srikakulam-plant/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.